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Pure neural leprosy, defined as a peripheral neuropathy in which the patient has no skin lesions, is 
difficult to diagnose. Its verification by bacteriological index and histopathology is not possible in the 
majority of the patients. 
We describe four cases of pure neural leprosy diagnosed by clinical criteria. The clinical outcome of 
three of the patients after specific treatment was satisfactory, while the other one developed progressive 
neural damage despite the therapy. All patients were treated in a specialized center for the management 
and control of Hansen’s disease in the municipality of Contratación, Santander, Colombia.
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Serie de casos de lepra neural pura en pacientes diagnosticados en un centro especializado en 
el control de la enfermedad de Hansen en Colombia
La lepra neural pura se presenta como una neuropatía periférica sin presencia de lesiones cutáneas. 
La verificación del diagnóstico mediante el índice bacilar y la histopatología, no es posible en la mayoría 
de los pacientes.
Se describen cuatro casos de lepra neural pura diagnosticados por clínica; la evolución de tres de los 
pacientes que recibieron tratamiento específico fue satisfactoria, en tanto que la otra paciente presentó 
deterioro progresivo a pesar de las medidas terapéuticas. Todos los pacientes fueron atendidos en un 
centro especializado en el manejo y control de la enfermedad de Hansen, ubicado en el municipio de 
Contratación, Santander, Colombia.
Palabras clave: lepra tuberculoide/diagnóstico; terapéutica; estudios de casos; Colombia.
doi: https://doi.org/10.7705/biomedica.v38i0.3690
Pure neural leprosy is a clinical form of Hansen’s 
disease that affects peripheral nerves without 
causing skin lesions in the patient (1,2). Therefore, 
its diagnosis is challenging due to the subjectivity 
and complexity of the clinical manifestations (3). 
Although its prevalence is low (5 to 18% of all leprosy 
diagnosis), it may be underestimated because 
simple, reliable and non-invasive diagnostic tools 
to detect Mycobacterium leprae in patients with this 
kind of leprosy are currently unavailable. Thus, its 
detection depends on the clinical experience of the 
physician (3,4).
The neural condition caused by leprosy results 
from the asymmetric invasion by M. leprae in 
peripheral nerve fibers, an interaction that causes 
an inflammatory response at the axon level, 
resulting in inflammation of peripheral nerve trunks 
(neuritis) and damaging sensory fibers responsible 
for exteroceptive sensitivity (5-7). Early pure neural 
leprosy symptoms occur when infection of the 
compromised sensory fibers exceeds 30% (8).
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The diagnosis of the condition is clinical, and it 
should be suspected in household contacts of 
patients with Hansen’s disease who display only 
peripheral damage as clinical symptom. Neuro-
pathic symptoms and signs should be a sufficient 
criterion of diagnosis when additional diagnostic 
studies are not possible, and when common causes 
of peripheral neuropathy (e.g. diabetes mellitus, 
alcoholism and carpal tunnel syndrome) have been 
ruled out (1,9)
While the absence of skin lesions complicates 
pure neural leprosy diagnosis, detecting M. leprae 
in biopsy smears (skin and peripheral nerve) is 
also difficult. Given that histopathological findings 
tend to be nonspecific, implementation of sero-
logical tests (such as the detection of IgM anti-
bodies against phenolic glycolipid - I (PLG-I) in 
patients with peripheral neuropathy may support 
its diagnosis (10).
We describe here four pure neural leprosy cases 
diagnosed in the Sanatorium of Contratación in 
Santander, Colombia.
Case 1
A 64-year-old male patient exhibiting 2 years of 
clinical symptoms characterized by muscle weak-
ness in the eyes, hands, and feet with associated 
sensory loss in these areas. 
The patient did not have a pathological, pharmacolo-
gical, surgical, or history of trauma to explain these 
symptoms. As regards the epidemiological nexus, 
the patient’s father and paternal uncles were both 
leprosy patients. In addition, the patient had lived 
for 20 years with a woman suffering from leprosy. 
Finally, the patient hunted and ate armadillo.
The physical examination did not reveal skin lesions. 
A neurological assessment of the face, head, and 
neck revealed an absence of the bilateral corneal 
reflex and weakness in the orbicular muscle of the 
eyelids involving the trigeminal and facial nerve. 
We performed a sensitivity evaluation using 
Semmes-Weinstein monofilaments. In the upper 
limbs, we observed sensory loss (anesthesia) in 
areas innervated by the radial median nerve and in 
the hands, in areas innervated by the ulnar nerve. 
We also found evidence of a bilateral thickening of 
the ulnar and right cutaneous radial nerves. We did 
not observe trophic changes in the hands (figure 1). 
In the lower limbs, sensory loss (anesthesia) 
was evident in both feet in areas innervated by 
the tibial posterior and fibular common nerves. 
During palpation of the nerve trunks, we detected 
a thickening of both tibial posterior nerves without 
trophic changes in the feet (figure 1). 
As regards laboratory tests, the bacilloscopy of the 
mucus and interstitial fluid did not detect acid-alcohol 
resistant bacilli (BAAR). Serology to detect IgG 
LID1-NOD (cut-off>0.146 optical density, OD) was 
positive (0.480 OD). IgM anti-PGL-1 (cut-off>0.162 
OD) was negative (0.095 OD). We ruled out damage 
to the central nervous system (CNS), as computeri-
zed axial tomography reported a normal status. 
Given the patient’s epidemiological nexus, evi-
dence of peripheral neuropathy and the presence 
of IgG antibodies against M. leprae proteins, we 
diagnosed the patient with pure neural leprosy.
The patient exhibited grade 1 disability of the eyes, 
hands, and feet and began multidrug therapy 
for multibacillary leprosy (MDT-MB). In addition, 
the patient began physical therapies plus cortico 
therapy with prednisolone in a descending scheme 
(60 mg initial doses) and four months later the 
progression of neural damage stopped. 
Table 1 shows the immunological, bacteriological, 
epidemiological, clinical, and diagnostic character-
istics of each of the patients reported in this study.
Case 2
A 33 year-old male patient exhibiting 3 years of 
clinical symptoms characterized by muscle weak-
ness in the hands with associated sensory loss in 
both his hands and feet. 
The patient did not have a pathological, pharmaco-
logical, surgical, or trauma history to explain these 
symptoms. Regarding the epidemiological nexus, 
his father is a leprosy patient. In addition, the patient 
also hunted and ate armadillo. 
Upon physical examination, we did not observe 
skin lesions. In the neurological assessment of 
face, head, and neck, we detected that the corneal 
reflex in the right eye involving the trigeminal nerve 
was absent. 
In the upper limbs, we observed sensory loss 
(anesthesia) in areas innervated by the median, 
ulnar and radial nerves in both hands (figure 2) and 
found evidence of a bilateral thickening of the ulnar 
nerve and percussing pain in the left median nerve. 
The Froment test was positive in both hands; we 
did not observe trophic changes in this area. 
In the lower limbs, we found evidence of sensory 
loss (anesthesia) in areas innervated by the tibial 
posterior and fibular common nerves in both feet. 
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During palpation of the nerve trunks, we detected a 
thickening of the right posterior tibial nerve without 
trophic changes in the feet (figure 2).
The bacilloscopy of the mucus and interstitial fluid 
did not detect BAAR. Serology to detect IgM against 
LID 1-NOD (cut-off>0.153 OD) was negative (0.072 
OD). IgM anti PGL-1 (cut-off>0.162 OD) was nega-
tive (0.081 OD).
Considering that this patient had a positive epi-
demiological nexus with Hansen’s disease and 
an asymmetrical peripheral neuropathy, he was 
diagnosed with pure neural leprosy with a grade 
1 disability (hands/feet) and started MDT-MB with 
prednisolone in a descending scheme (50 mg initial 
doses). Currently, the patient has finished MDT-
MB in combination with prednisolone; the clinical 
outcome was good since the disability grade did 
not increase (table 1).
Case 3
A 42-year-old female patient exhibiting 4 years of 
clinical symptoms characterized by weakness in 
the hands and lower limbs associated with sensory 
loss in those areas. 
She was initially diagnosed with carpal tunnel 
syndrome, and received surgical treatment (decom-
pression of the median nerve) in both hands. This 
diagnosis was established without considering the 
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Figure 1. Case 1 findings. SWM: Semmes-Weinsten monofilaments
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Table 1. Epidemiological, clinical, bacteriological and immunological characterization of the group of patients diagnosed with pure 
neural leprosy
Patients Epidemiological  
nexus 
Onset of 
symptoms
Involvement of 
sensitive area
Involvement 
of motor area
Nerve trunks 
affected
Serological 
tests 
Bacilloscopy Treatment
1 Parents and 
paternal uncles with 
leprosy Hunting and 
consumption 
of armadillo
2 years Eyes
Hands
Feet
Weakness in 
the orbicular 
of the eyelids 
(facial nerve)
Ulnar nerve R/L        
Radial nerve R         
Posterior tibial 
nerve R/L
*Positive 
0,480 OD  
** Negative 
0,095 OD
Negative MDT-MB + 
prednisolone
2 Father with 
leprosy
Hunting and 
consumption 
of armadillo
3 years Right eye 
Hands
Feet 
No trophic 
changes
Right and left 
ulnar nerves 
Left median 
nerve 
Right posterior 
tibial nerve
 ***Negative 
0,072 OD     
** Negative 
0,081 OD
Negative MDT-MB + 
prednisolone
3 Cousins with leprosy
Consumption 
of armadillo
3 years Eyes
Hands
Feet
No trophic 
changes
No thickening 
of nerves
*Negative 
0,109 OD       
** Negative 
0,096 OD
Negative MDT-PB + 
prednisolone
4 Grandparents 
with leprosy
4 years Hands Left hand, 
benediction 
hand
Left ulnar 
nerve 
* Negative 
0,111 OD     
** Negative 
0,098 OD
Negative MDT-MB + 
prednisolone
*IgG LID1-NOD (cut- off>0.146 OD); **IgM PGL-1 (cut- off >0.162 OD); ***IgM LID1-NOD (cut-off >0.153 OD); OD: Optical densities
clinical symptoms, which were compatible with 
multiplex mononeuropathy. The patient did not 
have a pathological, pharmacological, or trauma 
history to explain these symptoms. 
Regarding the epidemiological nexus, the patient 
had cousins suffering from leprosy and, besides, 
she ate armadillo. 
During the physical examination, no skin lesions 
were detected. In the neurological assessment of 
the face, head, and neck, we observed damage of 
the trigeminal nerve in both eyes. 
In the upper limbs, we observed sensory loss (anes-
thesia) in both hands associated with areas inner-
vated by the median, ulnar, and radial nerves. We 
found no evidence of a thickening of the peripheral 
nerve or of trophic changes in the hands (figure 3). 
In the lower limbs, we found evidence of sensory 
loss (anesthesia) in areas innervated by the tibial 
posterior and fibular common nerves in both feet, 
but no evidence of a thickening of the peripheral 
nerve or trophic changes in the feet (figure 3). 
With regard to laboratory tests, the bacilloscopy did 
not detect BAAR. Serology to detect IgG anti-LID 
1-NOD (cut-off>0.146 OD) was negative (0.109 
OD), as well as for IgM anti-PGL-1 (cut-off>0.162 
OD;0.096 OD). 
Considering this patient had a positive epidemio-
logical nexus with Hansen’s disease, as well as 
multiplex mononeuropathy without other possible 
pathologies to explain a neuropathic condition that 
differed from leprosy, she was diagnosed with pure 
neural leprosy and grade 1 disability (eyes/hands/
feet), and MDT for paucibacillary leprosy (PB) was 
started combined with physical therapy. Currently, 
the patient has improved her strength in hands 
and lower limbs and she continues with physical 
therapy (table 1).
Case 4
A 42-year-old female patient exhibiting 4 years 
of clinical symptoms characterized by decreased 
sensitivity in her hands and a retraction of the 
fourth and fifth finger of the left hand. 
The patient did not have a pathological, pharmaco-
logical, surgical, or trauma history to explain these 
symptoms. As regards the epidemiological nexus, 
the patient’s grandparents had leprosy. 
The physical examination did not reveal skin lesions 
and in the neurological assessment of her face, head, 
and neck, we did not detect damage in the trigemi-
nal or facial nerve. In her upper limbs, we observed 
sensory loss (anesthesia) in areas innervated by 
the median, ulnar, and radial nerves of the left hand, 
as well as a thickening of the left ulnar nerve. The 
Froment test was positive for her left hand and she 
had trophic changes (clawed left hand) (figure 4). 
In the lower limbs, we did not observe sensory or 
trophic changes in the feet (figure 4). 
The bacilloscopy was negative for BAAR. Serology 
to detect IgG anti-LID 1-NOD (cut-off>0.146 OD) 
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was negative (0.111 OD), and IgM anti-PGL-1 (cut-
off>0.162 OD) was also negative (0.098 OD). 
Given that the neurological impairment caused a 
grade 2 disability in her left hand, the patient was 
diagnosed with pure neural leprosy and began 
MDT-MB in combination with prednisolone in a 
descending scheme (40 mg initial doses), as well 
as physical therapies. Currently, she has received 
18 blisters of MDT-MB and she continues with 
prednisolone and physical therapy. However, de-
spite the treatment, her disability in the left hand 
is worst because of impairment of the radial nerve 
(table 1).
Electromyography test was not available for any 
of these patients.
Discussion
These cases show that pure neural leprosy 
represents a diagnostic challenge for healthcare 
personnel, even for those with extensive expertise, 
due to the fact that it typically affects the peripheral 
nervous system (PNS) as a mononeuropathy or 
multiplex mononeuropathy without causing skin 
lesions (11). Furthermore, confirming diagnosis 
by bacteriological and histopathological methods 
remains difficult, even via neural biopsy, which is 
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Figure 2. Case 2 findings. SWM: Semmes-Weinsten monofilaments
158
Biomédica 2018;38:153-61Serrano-Coll H, Mieles O, Escorcia C, et al. 
considered as the gold standard for the diagnosis. 
The difficulty is primarily explained by the low 
bacillary load that is typical of this form of leprosy, 
and the fact that the histopathological changes 
associated with this condition are also present in 
other neuropathies, particularly vasculitis, and in 
chronic inflammatory demyelinating polyneuropathy 
(CIDP) (12). However, histopathological findings 
such as endoneural inflammation and epithelioid 
granulomas in the peripheral nerves of patients with 
epidemiological nexus and clinical manifestations 
of neural impairment are the major criteria for the 
diagnosis of pure neural leprosy (13). Furthermore, 
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Figure 3. Case 3 findings. SWM: Semmes-Weinsten monofilaments
the electromyography can be an important tool in 
the detection of the nerve damage, and to deter-
mine the best place to take the biopsy, improving 
the sensitivity of the histopathology (1,6).
Today, the presence of M. leprae may be detected 
using other diagnostic alternatives, such as poly-
merase chain reaction (PCR), serological methods 
to detect antibodies against PGL-I or fine needle 
aspiration (FNA) cytology (14).
Reja, et al. (4), conducted a study using FNA in 
13 patients with pure neural leprosy to demonstrate 
the presence of M. leprae through multiplex PCR 
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Figure 4. Case 4 findings. SWM: Semmes-Weinsten monofilaments
and Ziehl-Neelsen (ZN) staining. Multiplex PCR 
detected the presence of mycobacteria in 11 
patients (84.6%) and ZN staining showed BAAR 
in 5 patients (38.4%). The authors concluded that 
a combination of multiplex PCR and ZN staining 
(from FNA) provided a rapid and reliable diagnosis 
of the disease (4). Grossi, et al. (15), showed that 
serology can be useful in detecting and monitoring 
the disease given that subjects with more than 
one nerve trunk are four times more likely to be 
seropositive (15).
The use of serological tests such as PGL-I or NDO-
LID could also be useful in the detection of pure 
neural leprosy as positivity of these serological 
tests is considered a diagnostic criterion for this 
condition. Moreover, it is important to mention that 
these tests are positive only in less than 50% of 
the patients with pure neural leprosy. Therefore, 
a negative serological test does not discard its 
presence (1).
Regarding the personal history of these four cases, 
it should be mentioned that all of them were both 
household contacts of patients with Hansen’s 
disease and blood-related. Thus, the patients had a 
10 to 14 times more risk of contracting the disease 
than the general population (16). It is important to 
note that three of the four patients examined had 
contact with armadillos, that leprosy is considered a 
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zoonotic disease and that they have tested positive 
for M. leprae in Colombia (17). Truman, et al. (18) 
confirmed the zoonotic transmission of leprosy: 25 
patients with Hansen’s disease and 28 armadillos 
infected with leprosy shared the same M. leprae 
strain (18). Therefore, in patients with peripheral 
neuropathy of unknown etiology, it is important that 
physicians inquire about the personal history of 
their leprosy patients and whether there has been 
contact with animals that might be related to the 
transmission of the disease (16,19,20).
The classification of pure neural leprosy is usually 
paucibacillary (PB) (17), although Rodríguez, et al. 
(1), have recommended to consider the number 
of peripheral nerve trunks affected to begin the 
treatment: patients with two or more affected 
peripheral nerve trunks should start MDT-MB for 
12 months (1). Furthermore, patients can improve 
their neurological condition using steroids such as 
prednisolone in 40 to 60 mg doses. However, Smith, 
et al. (21), observed that the use of prednisolone 
in 20 mg doses had similar effects to avoid the 
impairment of nerves in leprosy patients. 
In conclusion, pure neural leprosy is an enigmatic 
and often silent entity that primarily affects house-
hold contacts of Hansen’s disease patients and 
its diagnosis is clinical. The disease is often dis-
regarded for the differential diagnosis of possible 
peripheral neuropathy. It is, therefore, imperative 
that the medical personnel include it in their diag-
nostic possibilities. 
Finally, it is necessary to continue working on reli-
able, non-invasive diagnostic techniques, possibly 
through a combination of serological and genomic 
tools. The combined use of these tests and of 
medical devices for the early detection of periph-
eral neuropathy would facilitate the early diagnosis 
of pure neural leprosy and mitigate the progression 
of disabilities caused by neural damage.
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